Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000470065 | SCV000544342 | benign | Tuberous sclerosis 2 | 2024-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000565878 | SCV000675585 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001696873 | SCV000718051 | likely benign | not provided | 2021-03-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000470065 | SCV002039362 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000565878 | SCV002533439 | benign | Hereditary cancer-predisposing syndrome | 2021-02-17 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002506104 | SCV002808331 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2022-05-26 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003387848 | SCV004099680 | benign | not specified | 2023-09-10 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004000684 | SCV004823469 | benign | Tuberous sclerosis syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing |